Literature DB >> 10764799

Selective attenuation of metabolic branch of insulin receptor down-signaling by high glucose in a hepatoma cell line, HepG2 cells.

K Nakajima1, K Yamauchi, S Shigematsu, S Ikeo, M Komatsu, T Aizawa, K Hashizume.   

Abstract

The effects of a high concentration of glucose on the insulin receptor-down signaling were investigated in human hepatoma (HepG2) cells in vitro to delineate the molecular mechanism of insulin resistance under glucose toxicity. Treatment of the cells with high concentrations of glucose (15-33 mm) caused phosphorylation of serine residues of the insulin receptor substrate 1 (IRS-1), leading to reduced electrophoretic mobility of it. The phosphorylation of IRS-1 with high glucose treatment was blocked only by protein kinase C (PKC) inhibitors. The high glucose treatment attenuated insulin-induced association of IRS-1 and phosphatidylinositol 3-kinase and insulin-stimulated phosphorylation of Akt. A metabolic effect of insulin, stimulation of glycogen synthesis, was also inhibited by the treatment. In contrast, insulin-induced association of Shc and Grb2 was not inhibited. Treatment of the cells with high glucose promoted the translocation of PKCepsilon and PKCdelta from the cytosol to the plasma membrane but not that of other PKC isoforms. Finally, PKCepsilon and PKCdelta directly phosphorylated IRS-1 under cell-free conditions. We conclude that a high concentration of glucose causes phosphorylation of IRS-1, leading to selective attenuation of metabolic signaling of insulin. PKCepsilon and PKCdelta are involved in the down-regulation of insulin signaling, and they may lie in a pathway regulating the phosphorylation of IRS-1.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10764799     DOI: 10.1074/jbc.M905410199

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

Review 1.  The role of protein kinase C isoforms in insulin action.

Authors:  P Formisano; F Beguinot
Journal:  J Endocrinol Invest       Date:  2001-06       Impact factor: 4.256

2.  Selective serotonin reuptake inhibitors (SSRIs) inhibit insulin secretion and action in pancreatic β cells.

Authors:  Roi Isaac; Sigalit Boura-Halfon; Diana Gurevitch; Alla Shainskaya; Yechiel Levkovitz; Yehiel Zick
Journal:  J Biol Chem       Date:  2012-12-28       Impact factor: 5.157

3.  Insulin-like growth factor-I-stimulated insulin receptor substrate-1 negatively regulates Src homology 2 domain-containing protein-tyrosine phosphatase substrate-1 function in vascular smooth muscle cells.

Authors:  Yashwanth Radhakrishnan; Walker H Busby; Xinchun Shen; Laura A Maile; David R Clemmons
Journal:  J Biol Chem       Date:  2010-03-05       Impact factor: 5.157

Review 4.  IRS posttranslational modifications in regulating insulin signaling.

Authors:  Jinghua Peng; Ling He
Journal:  J Mol Endocrinol       Date:  2017-11-01       Impact factor: 5.098

5.  Sequential cleavage of insulin receptor by calpain 2 and γ-secretase impairs insulin signalling.

Authors:  Tomoyuki Yuasa; Kikuko Amo-Shiinoki; Shuhei Ishikura; Mitsuyoshi Takahara; Takaaki Matsuoka; Hideaki Kaneto; Akio Kuroda; Munehide Matsuhisa; Seiichi Hashida
Journal:  Diabetologia       Date:  2016-09-30       Impact factor: 10.122

6.  S6K directly phosphorylates IRS-1 on Ser-270 to promote insulin resistance in response to TNF-(alpha) signaling through IKK2.

Authors:  Jin Zhang; Zhanguo Gao; Jun Yin; Michael J Quon; Jianping Ye
Journal:  J Biol Chem       Date:  2008-10-24       Impact factor: 5.157

7.  In skeletal muscle advanced glycation end products (AGEs) inhibit insulin action and induce the formation of multimolecular complexes including the receptor for AGEs.

Authors:  Angela Cassese; Iolanda Esposito; Francesca Fiory; Alessia P M Barbagallo; Flora Paturzo; Paola Mirra; Luca Ulianich; Ferdinando Giacco; Claudia Iadicicco; Angela Lombardi; Francesco Oriente; Emmanuel Van Obberghen; Francesco Beguinot; Pietro Formisano; Claudia Miele
Journal:  J Biol Chem       Date:  2008-10-27       Impact factor: 5.157

8.  Overproduction of phosphoprotein enriched in diabetes (PED) induces mesangial expansion and upregulates protein kinase C-beta activity and TGF-beta1 expression.

Authors:  F Oriente; S Iovino; A Cassese; C Romano; C Miele; G Troncone; M Balletta; A Perfetti; G Santulli; G Iaccarino; R Valentino; F Beguinot; P Formisano
Journal:  Diabetologia       Date:  2009-09-30       Impact factor: 10.122

9.  Insulin-like growth factor-I stimulates Shc-dependent phosphatidylinositol 3-kinase activation via Grb2-associated p85 in vascular smooth muscle cells.

Authors:  Yashwanth Radhakrishnan; Laura A Maile; Yan Ling; Lee M Graves; David R Clemmons
Journal:  J Biol Chem       Date:  2008-04-16       Impact factor: 5.157

10.  SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase.

Authors:  Xiuyun Hou; Shanqin Xu; Karlene A Maitland-Toolan; Kaori Sato; Bingbing Jiang; Yasuo Ido; Fan Lan; Kenneth Walsh; Michel Wierzbicki; Tony J Verbeuren; Richard A Cohen; Mengwei Zang
Journal:  J Biol Chem       Date:  2008-05-14       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.